Report : Middle East & Africa Cartilage degeneration Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Procedure Type (Osteochondral Transplant, Chondroplasty, Joint Replacement, Meniscus Transplants, Cell-based Cartilage Resurfacing, and Others), Application (Knee, Hips and Others), and End User (Hospitals & Specialty Clinics, and Ambulatory Surgical Centers and Academic & Research Institutes) and Geography
KneeSegment Held Largest Share of Cartilage Degeneration Market in 2019
According to our new market research study on “Middle East & AfricaCartilage Degeneration Marketto 2027 – Regional Analysis and Forecast – by Procedure Type, Applicationand EndUser”the market is expected to reach US$511.76 millionby 2027 from US$ 426.91 million in 2019; it is estimated to grow at a CAGR of 2.4% from 2020 to 2027. The report provides trends prevailing in the Middle East & Africacartilage degenerationmarket and the factors driving the market growth along with those hindering it.
In 2019, the knee segment accounted for the highest share of the market. Growth of this segment is attributed to the increasing prevalence of knee injuries. Furthermore, increasing awareness of benefits provided by cartilage repair is also anticipated to drive the growth of knee segment.
The growth of the Middle East & Africacartilage degeneration marketis mainly attributed togrowing number of sports injuries, and increasing prevalence of obesity. However, high cost of cartilage repair therapies is expected to restrict the market growth during the forecast period.
The Report Segments Middle East & AfricaCartilage DegenerationMarketas Follows:
Middle East & AfricaCartilage DegenerationMarket– By ProcedureType
Middle East & AfricaCartilage Degeneration Market – By Application
Middle East & AfricaCartilage DegenerationMarket– By Country